Key points are not available for this paper at this time.
INTRODUCTION: Alzheimer's disease is a type of dementia, and till now there is no suitable drug available for the complete cure of this disease. Now-a-days Probiotics, Lactobacillus strains play a therapeutic role in cognitive disorders through Gut-Brain Axis communication. AIM: MTCC1325 against D-Galactose-induced Alzheimer's disease in albino rats. MATERIALS AND METHODS: MTCC1325 for 60 days. During the experimentation, both morphometric and behavioural aspects were studied. Later we have examined histopathological changes and estimated cholinergic levels in selected brain regions of all experimental groups of rats including control on selected days. RESULTS: alone. CONCLUSION: MTCC1325 might have anti-Alzheimer properties against D-Galactose induced Alzheimer's disease.
Mallikarjuna Nimgampalle (Sun,) studied this question.